Waddell & Reed Financial’s Kite Pharma, Inc. KITE Stock Holding History

Waddell & Reed Financial’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-950,600	Closed	-$171M	–	579
2017 Q3	$171M	Sell	950,600 -54,200	-5%	-$7.55M	0.38%	68
2017 Q2	$104M	Buy	1,004,800 +50,000	+5%	+$4.08M	0.23%	118
2017 Q1	$74.9M	Buy	954,800 +247,200	+35%	+$15.3M	0.16%	165
2016 Q4	$31.7M	Sell	707,600 -8,100	-1%	-$397K	0.07%	277
2016 Q3	$40M	Buy	+715,700	New	+$39.9M	0.08%	233

Waddell & Reed Financial's KITE Position: Q4 2017 in Review

Waddell & Reed Financial sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 950,600 shares — an estimated $171M sold.

Waddell & Reed Financial first reported a position in KITE in Q3 2016 and held it in 5 quarters. The position peaked at $171M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Waddell & Reed Financial reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Waddell & Reed Financial sold 950,600 Kite Pharma, Inc. shares in Q4 2017, an estimated $171M.
Waddell & Reed Financial first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 5 quarters.
Waddell & Reed Financial's Kite Pharma, Inc. position peaked at $171M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Waddell & Reed Financial's 13F filing for Q4 2017, filed 14 Feb 2018.